Evinacumab. Anti-ANGPTL3 (angiopoietin-like protein 3) monoclonal antibody, Treatment of homozygous familial hypercholesterolemia, Treatment of dyslipidemia and cardiovascular disease

Autor:	B. A. Warden, P. B. Duell
Rok vydání:	2020
Předmět:	medicine.medical_specialty medicine.drug_class business.industry Evinacumab Hypertriglyceridemia Disease Familial hypercholesterolemia Monoclonal antibody medicine.disease Endocrinology Angiopoietin-like Protein ANGPTL3 Internal medicine medicine business Dyslipidemia
Zdroj:	Drugs of the Future. 45:619
ISSN:	2013-0368
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a3b794bcefc791a0eee660a18f04a0e3 https://doi.org/10.1358/dof.2020.45.9.3178109 Zobrazit plný text záznamu